These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 10690864)
1. The effect of hormone replacement therapy on cardiovascular hemodynamics in women with Turner's syndrome. Elsheikh M; Bird R; Casadei B; Conway GS; Wass JA J Clin Endocrinol Metab; 2000 Feb; 85(2):614-8. PubMed ID: 10690864 [TBL] [Abstract][Full Text] [Related]
2. Body composition and physical fitness are major determinants of the growth hormone-insulin-like growth factor axis aberrations in adult Turner's syndrome, with important modulations by treatment with 17 beta-estradiol. Gravholt CH; Naeraa RW; Fisker S; Christiansen JS J Clin Endocrinol Metab; 1997 Aug; 82(8):2570-7. PubMed ID: 9253336 [TBL] [Abstract][Full Text] [Related]
3. Glucose metabolism, lipid metabolism, and cardiovascular risk factors in adult Turner's syndrome. The impact of sex hormone replacement. Gravholt CH; Naeraa RW; Nyholm B; Gerdes LU; Christiansen E; Schmitz O; Christiansen JS Diabetes Care; 1998 Jul; 21(7):1062-70. PubMed ID: 9653596 [TBL] [Abstract][Full Text] [Related]
4. Lp(a) and lipids in adult Turner's syndrome: impact of treatment with 17beta-estradiol and norethisterone. Gravholt CH; Christian Klausen I; Weeke J; Sandahl Christiansen J Atherosclerosis; 2000 May; 150(1):201-8. PubMed ID: 10781652 [TBL] [Abstract][Full Text] [Related]
5. Exaggerated effects of progestogen on uterine artery pulsatility index in Turner's syndrome patients receiving hormone replacement therapy. Biljan MM; Taylor CT; Matijevic R; Jones SV; Garden AS; Fraser WD; Diver MJ; Kingsland CR Fertil Steril; 1995 Dec; 64(6):1104-8. PubMed ID: 7589660 [TBL] [Abstract][Full Text] [Related]
6. [Effect of hormone replacement therapy on lipid metabolism in patients with premature ovarian failure and Turner's syndrome]. Yahata T; Kurabayashi T; Kato R; Yamamoto Y; Fujimaki T; Yasuda M; Oda K; Yoshizawa H; Tanaka K Nihon Sanka Fujinka Gakkai Zasshi; 1994 Nov; 46(11):1197-204. PubMed ID: 7844437 [TBL] [Abstract][Full Text] [Related]
8. Aortic distensibility and dilation in Turner's syndrome. Sharma J; Friedman D; Dave-Sharma S; Harbison M Cardiol Young; 2009 Dec; 19(6):568-72. PubMed ID: 19857368 [TBL] [Abstract][Full Text] [Related]
9. Metabolic and cardiovascular outcomes in a group of adult patients with Turner's syndrome under hormonal replacement therapy. Giordano R; Forno D; Lanfranco F; Manieri C; Ghizzoni L; Ghigo E Eur J Endocrinol; 2011 May; 164(5):819-26. PubMed ID: 21378088 [TBL] [Abstract][Full Text] [Related]
10. Pregnancies in women with Turner's syndrome. Hovatta O Ann Med; 1999 Apr; 31(2):106-10. PubMed ID: 10344582 [TBL] [Abstract][Full Text] [Related]
11. Hormone replacement therapy may improve hepatic function in women with Turner's syndrome. Elsheikh M; Hodgson HJ; Wass JA; Conway GS Clin Endocrinol (Oxf); 2001 Aug; 55(2):227-31. PubMed ID: 11531930 [TBL] [Abstract][Full Text] [Related]
12. Hypertension is a major risk factor for aortic root dilatation in women with Turner's syndrome. Elsheikh M; Casadei B; Conway GS; Wass JA Clin Endocrinol (Oxf); 2001 Jan; 54(1):69-73. PubMed ID: 11167928 [TBL] [Abstract][Full Text] [Related]
13. The effects of hormone replacement therapy on endothelial function in women with Turner's syndrome. Chan NN; Vallance P; Colhoun HM; MacAllister RJ; Hingorani AD; Conway GS Clin Endocrinol (Oxf); 2002 May; 56(5):615-20. PubMed ID: 12030912 [TBL] [Abstract][Full Text] [Related]
14. The impact of obesity on cardiovascular risk factors in Turner's syndrome. Elsheikh M; Conway GS Clin Endocrinol (Oxf); 1998 Oct; 49(4):447-50. PubMed ID: 9876341 [TBL] [Abstract][Full Text] [Related]
15. Volumetric bone mineral density in young women with Turner's syndrome treated with estrogens or estrogens plus growth hormone. Bertelloni S; Cinquanta L; Baroncelli GI; Simi P; Rossi S; Saggese G Horm Res; 2000; 53(2):72-6. PubMed ID: 10971092 [TBL] [Abstract][Full Text] [Related]
16. A longitudinal study of the effect of subcutaneous estrogen replacement on bone in young women with Turner's syndrome. Khastgir G; Studd JW; Fox SW; Jones J; Alaghband-Zadeh J; Chow JW J Bone Miner Res; 2003 May; 18(5):925-32. PubMed ID: 12733734 [TBL] [Abstract][Full Text] [Related]
17. Insulin resistance is an intrinsic defect independent of fat mass in women with Turner's syndrome. Salgin B; Amin R; Yuen K; Williams RM; Murgatroyd P; Dunger DB Horm Res; 2006; 65(2):69-75. PubMed ID: 16407654 [TBL] [Abstract][Full Text] [Related]
18. Liver dysfunction in Turner's syndrome: prevalence, natural history and effect of exogenous oestrogen. Koulouri O; Ostberg J; Conway GS Clin Endocrinol (Oxf); 2008 Aug; 69(2):306-10. PubMed ID: 18248644 [TBL] [Abstract][Full Text] [Related]
19. Gonadotropin levels in Turner's syndrome: correlation with breast development and hormone replacement therapy. Alves ST; Gallicchio CT; Guimarães MM; Santos M Gynecol Endocrinol; 2003 Aug; 17(4):295-301. PubMed ID: 14503973 [TBL] [Abstract][Full Text] [Related]
20. Pituitary response to synthetic luteinizing hormone-releasing hormone in patients with Turner's syndrone. Huang KE J Clin Endocrinol Metab; 1975 Oct; 41(4):771-6. PubMed ID: 1100644 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]